BioNTech to buy CureVac in $1.25 billion deal, saying it will bolster cancer work
BioNTech said Thursday it would buy CureVac, its onetime competitor in the Covid-19 vaccine race, for about $1.25 billion in an all-stock transaction.
Related Articles
I’m a fertility doctor, and I think IVF needs more regulation
An IVF doctor and clinic founder writes that his industry needs increased governmental oversight and more comprehensive regulations, not less.
Even full fetal personhood shouldn’t end abortion rights
The law shouldn’t force pregnant people to assume greater duties to their fetuses than parents have to their children.
Sarepta reports second patient death after treatment with Duchenne gene therapy
Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death of a second recipient.
Medicare Advantage’s supplemental benefits will cost taxpayers $86 billion this year, with little transparency
Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for their members, or 17% of total
Sarepta reports second patient death after treatment with Duchenne gene therapy
Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death of a second recipient.
A closer look at the new members of the CDC vaccine advisory panel
For more than a half-century, the Centers for Disease Control and Prevention have relied on outside experts to guide the agency’s recommendations on how
I’m adopted. I still won’t use genetic testing services like 23andMe
A company like 23andMe can answer a lot of questions for an adoptee. But those answers come with a high cost to privacy.
Why autism researchers aren’t convinced NIH can keep science and politics separate
A new $50 million NIH initiative to find the causes of autism faces questions about transparency and independence.
How physicians like me are grappling with requests for unvaccinated donor blood
As a transfusion medicine physician, Jeremy W. Jacobs has increasingly faced requests for “unvaccinated donor blood.” So he and colleagues looked closer at what the…
By remaking CDC’s vaccine advisory panel, RFK Jr. is destroying public trust
Eliminating ACIP’s expertise on the eve of critical votes about flu and RSV vaccines will delay guidance, confuse clinicians, and cost lives.
